ArticleEuropean journal of heart failure2022

Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.

Stuart J Pocock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.